Use of insulin-like growth factors I and II for inhibition of inflammatory response

Details for Australian Patent Application No. 2005201558 (hide)

Owner Novartis AG

Inventors Not Given

Agent Davies Collison Cave

Pub. Number AU-A-2005201558

Parent 779507

Filing date 13 April 2005

Wipo publication date 5 May 2005

International Classifications

A61K 038/30 Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

Event Publications

28 April 2005 Complete Application Filed

5 May 2005 Application Open to Public Inspection

  Published as AU-A-2005201558

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201559-Encapsulation of oxygen sensitive agents

2005201557-Apparatus, methods and packaging for preparing compositions